Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Dog (Canine) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
We have now identified A-44G as an additional positive disease modifier, present in a group of patients carrying 3 SMN2 (zeige SMN1 Antikörper) copies. Through systematic mutagenesis, we found that the improvement in exon 7 splicing is mainly attributable to the A-44G transition in intron 6.
Ongoing research may yield other treatments, especially for children who have not responded to Spinraza. A gene therapy delivered by adeno (zeige ADORA2A Antikörper)-associated virus type 9 (AAV9) is designed to replace or correct SMN1 (zeige SMN1 Antikörper) . Cure SMA (zeige SMN1 Antikörper) is supporting research in this area as well as studies of small molecules that correct SMN2 (zeige SMN1 Antikörper) splicing or spur it to produce more protein.
To determine the dependence of oligodendrocyte (OL)on the Smn (zeige STMN1 Antikörper) protein(SMN1 (zeige SMN1 Antikörper)), we utilized the Smn (zeige STMN1 Antikörper)-/-;SMN2 (zeige SMN1 Antikörper) (severe) mouse model. Our data suggest that despite the multi-functionality and ubiquitous expression of the Smn (zeige STMN1 Antikörper) protein, it does not play a key role in myelination of the CNS, at least in the context of spinal muscular atrophy pathogenesis.
The spleen is disproportionately small in the murine model of spinal muscular atrophy with a deficiency in SMN2 (zeige SMN1 Antikörper).
Low SMN2 (zeige SMN1 Antikörper) expression is associated with Spinal Muscular Atrophy.
we have characterized SMN (zeige STMN1 Antikörper)-C1, a low-molecular weight compound that corrects alternative splicing defects of SMN2 (zeige SMN1 Antikörper) exon 7. We evaluated SMN (zeige STMN1 Antikörper)-C1 pharmacokinetics in mice, the dose-response of SMN (zeige STMN1 Antikörper)-C1 induction of SMN (zeige STMN1 Antikörper) protein in two mouse models of SMA (zeige SMN1 Antikörper), the correlation between SMN (zeige STMN1 Antikörper)-C1 PK and SMN (zeige STMN1 Antikörper) protein induction in vivo, and demonstrated that the peripheral SMN (zeige STMN1 Antikörper) protein levels correlated with CNS SMN (zeige STMN1 Antikörper) protein levels
Deletion in SMN2 (zeige SMN1 Antikörper) gene is associated with spinal muscular atrophy.
Thus, we can conclude that SMN2 (zeige SMN1 Antikörper) methylation may regulate the SMA (zeige SMN1 Antikörper) disease phenotype by modulating its transcription.
This study demonstrated that Deficiency of the Survival of SMN2 (zeige SMN1 Antikörper) Impairs mRNA Localization and Local Translation in the Growth Cone of Motor Neurons
Inverse correlation was observed between SMN2 (zeige SMN1 Antikörper), SERF1A and NAIP (zeige NAIP Antikörper) copy number polymorphism and spinal muscular atrophy type.
This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. The telomeric and centromeric copies of this gene are nearly identical and encode the same protein. While mutations in the telomeric copy are associated with spinal muscular atrophy, mutations in this gene, the centromeric copy, do not lead to disease. This gene may be a modifier of disease caused by mutation in the telomeric copy. The critical sequence difference between the two genes is a single nucleotide in exon 7, which is thought to be an exon splice enhancer. Note that the nine exons of both the telomeric and centromeric copies are designated historically as exon 1, 2a, 2b, and 3-8. It is thought that gene conversion events may involve the two genes, leading to varying copy numbers of each gene. The full length protein encoded by this gene localizes to both the cytoplasm and the nucleus. Within the nucleus, the protein localizes to subnuclear bodies called gems which are found near coiled bodies containing high concentrations of small ribonucleoproteins (snRNPs). This protein forms heteromeric complexes with proteins such as SIP1 and GEMIN4, and also interacts with several proteins known to be involved in the biogenesis of snRNPs, such as hnRNP U protein and the small nucleolar RNA binding protein. Four transcript variants encoding distinct isoforms have been described.
component of gems 1
, survival motor neuron protein
, tudor domain containing 16B
, survival of motor neuron 2, centromeric